CICC Qide is a China-focused biomedicine and healthcare investment fund managed by CICC Capital, the private equity arm of China International Capital Corporation, backing clinical-stage pharmaceutical and biotech companies through late-stage and pre-IPO rounds.

1+ investments · 1 portfolio companies

Early Stage
Growth
Late Stage
Biotech
Portfolio Company
1
Total Investment
1
Last Investment
Jun 2020
Geographic Focus
China

Investment Thesis

Backs China's biomedicine and healthcare innovators, from clinical-stage biopharma to medical device makers, through growth and pre-IPO financings, often co-investing alongside global names like AstraZeneca and Carlyle.

CICC Qide is a Venture Capital firm. It has made 1 investment, including CF PharmTech. Focus areas include Biotech.

Portfolio1

Co-investors8

Sign up to view co-investors

8 co-investors across 8 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×8 · 4 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

CICC Qide on Indexed.vc
<a href="https://indexed.vc/investors/cicc-qide"><img src="https://indexed.vc/api/badge/investor/cicc-qide" alt="CICC Qide on Indexed.vc" width="260" height="76" /></a>